HYPERSENSITIVITY is the #13 most commonly reported adverse reaction for ADAPALENE, manufactured by Alchemee, LLC. There are 8,305 FDA adverse event reports linking ADAPALENE to HYPERSENSITIVITY. This represents approximately 2.0% of all 416,192 adverse event reports for this drug.
Patients taking ADAPALENE who experience hypersensitivity should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
HYPERSENSITIVITY8,305 of 416,192 reports
HYPERSENSITIVITY is a less commonly reported adverse event for ADAPALENE, but still significant enough to appear in the safety profile.
Other Side Effects of ADAPALENE
In addition to hypersensitivity, the following adverse reactions have been reported for ADAPALENE:
HYPERSENSITIVITY has been reported as an adverse event in 8,305 FDA reports for ADAPALENE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is HYPERSENSITIVITY with ADAPALENE?
HYPERSENSITIVITY accounts for approximately 2.0% of all adverse event reports for ADAPALENE, making it a notable side effect.
What should I do if I experience HYPERSENSITIVITY while taking ADAPALENE?
If you experience hypersensitivity while taking ADAPALENE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.